EUVIMEDEUVIMED entdecken
Crossref

A Rare Case of Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient after Liver Transplantation

Lyazzat Bekenkyzy Nur, Marzhan Marzhan, Aibar Aginbay, Kulpash Kaliaskarova, Zhanat Spatayev, Jamilya Saparbay, Bairam Kochiyev

Oncology, Nuclear Medicine and Transplantology · 2026

DOI: 10.63946/onmt/17728 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology, Nuclear Medicine and Transplantology, 2026. Verfasst von Lyazzat Bekenkyzy Nur und 6 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Posterior reversible encephalopathy syndrome (PRES) is a neurological condition characterized by seizures, encephalopathy, visual disturbances, and headache, often occurring in the context of hypertension and immunosuppressive therapy after solid organ transplantation. Although classically presenting with vasogenic edema in the parieto-occipital regions, atypical patterns may also occur. Here we report our experience with a case of cyclosporine-related PRES after liver transplant and summarize PRES clinical features through a literature review.

The case was a 53-year-old man who received a deceased donor liver transplant. His initial immunosuppressive therapy comprised cyclosporine/mycophenolate mofetil/prednisolone. Five months after transplantation, he was admitted to our center with altered mental status. The patient was diagnosed with PRES based on neurological symptoms and neuroimaging findings and recovered after switching from cyclosporine to everolimus. In addition, the lowering of blood pressure with drugs reported in the literature for use in PRES proved to be effective but challenging, requiring the use of multiple agents and only slowly leading to adequate control of hypertensive peaks. Nonetheless, hypertension management and supportive therapy allowed for a complete neurological recovery of the patient.

In conclusion, cyclosporine-associated PRES has a generally favorable prognosis with early diagnosis and prompt treatment, including altering or discontinuing CNIs and controlling blood pressure. CNI-associated PRES should be considered in patients exhibiting acute neurological symptoms after transplantation. Early diagnosis and immediate treatment are critical for a favorable prognosis.

Zitieren

APA

Nur, L. B., Marzhan, M., Aginbay, A., Kaliaskarova, K., Spatayev, Z., Saparbay, J., & Kochiyev, B. (2026). A Rare Case of Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient after Liver Transplantation. Oncology, Nuclear Medicine and Transplantology. https://doi.org/10.63946/onmt/17728

Vancouver

Nur LB, Marzhan M, Aginbay A, Kaliaskarova K, Spatayev Z, Saparbay J, et al. A Rare Case of Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient after Liver Transplantation. Oncology, Nuclear Medicine and Transplantology. 2026. doi:10.63946/onmt/17728

BibTeX
@article{Nur2026,
  author = {Nur, Lyazzat Bekenkyzy and Marzhan, Marzhan and Aginbay, Aibar and Kaliaskarova, Kulpash and Spatayev, Zhanat and Saparbay, Jamilya and Kochiyev, Bairam},
  title = {A Rare Case of Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient after Liver Transplantation},
  journal = {Oncology, Nuclear Medicine and Transplantology},
  year = {2026},
  doi = {10.63946/onmt/17728}
}
Kostenlos starten →